MeSH term
Frequency | Condition_Probility | Animals | 29 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Mutation | 6 | 0.0 |
Rats | 6 | 0.0 |
Recombination, Genetic | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Cell Line | 18 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/chemistry/*metabolism | 4 | 36.0 |
Humans | 75 | 0.0 |
*MAP Kinase Signaling System | 2 | 1.0 |
Phosphorylation | 29 | 0.0 |
Transcription Factors/chemistry/*metabolism | 4 | 2.0 |
Blotting, Western | 3 | 0.0 |
Cells, Cultured | 4 | 0.0 |
DNA/metabolism | 3 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Enzyme Activation | 10 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 5 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Protein Binding | 7 | 0.0 |
Protein Kinases/*metabolism | 4 | 1.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Time Factors | 7 | 0.0 |
Trans-Activation (Genetics) | 8 | 0.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Tyrosine/metabolism | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 18 | 2.0 |
Female | 6 | 0.0 |
In Vitro | 2 | 0.0 |
Labor, Obstetric/*metabolism | 2 | 15.0 |
Middle Aged | 3 | 0.0 |
Myometrium/*metabolism | 2 | 7.0 |
Pregnancy/*metabolism | 2 | 3.0 |
*Repressor Proteins | 2 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Lipopolysaccharides/pharmacology | 3 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Carcinoma, Hepatocellular | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Genes, Reporter | 4 | 0.0 |
Leucine Zippers | 4 | 2.0 |
*MAP Kinase Kinase Kinase 1 | 4 | 2.0 |
Molecular Sequence Data | 22 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
*Promoter Regions (Genetics) | 9 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 7 | 0.0 |
Proto-Oncogene Proteins c-jun/*genetics | 2 | 9.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Homology, Amino Acid | 8 | 0.0 |
Transcription Factors/metabolism | 16 | 1.0 |
Apoptosis | 2 | 0.0 |
DNA Repair | 3 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*metabolism | 8 | 10.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Luciferases/metabolism | 3 | 0.0 |
Mice | 15 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 36 | 0.0 |
Transcription Factors/*metabolism | 9 | 0.0 |
Transcription, Genetic | 8 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
DNA Damage | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 3 | 0.0 |
Gamma Rays | 2 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Tumor Cells, Cultured | 15 | 0.0 |
Adult | 5 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/genetics/metabolism | 2 | 13.0 |
Immunoblotting | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Protein Biosynthesis | 4 | 0.0 |
TNF Receptor-Associated Factor 2 | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*biosynthesis/genetics | 2 | 2.0 |
Base Sequence | 16 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 13 | 10.0 |
Promoter Regions (Genetics) | 10 | 0.0 |
Proto-Oncogene Proteins c-jun/metabolism | 8 | 5.0 |
Response Elements | 2 | 0.0 |
Drug Resistance, Neoplasm | 3 | 0.0 |
Enzyme Inhibitors/pharmacology | 8 | 0.0 |
Gene Expression | 3 | 0.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors | 2 | 3.0 |
Tumor Cells, Cultured/drug effects/radiation effects | 2 | 11.0 |
Ultraviolet Rays | 7 | 1.0 |
Cell Nucleus/metabolism | 4 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
PC12 Cells | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
Cattle | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 5 | 0.0 |
Trans-Activation (Genetics)/physiology | 2 | 2.0 |
JNK Mitogen-Activated Protein Kinases | 13 | 2.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 2 | 0.0 |
Mitogen-Activated Protein Kinase 3 | 2 | 0.0 |
Trans-Activators/metabolism | 3 | 0.0 |
Transfection | 15 | 0.0 |
Apoptosis/*radiation effects | 2 | 4.0 |
*Down-Regulation | 3 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 5 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*biosynthesis | 2 | 66.0 |
Transcription Factors/*biosynthesis | 2 | 1.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*physiology | 2 | 8.0 |
Plasmids | 3 | 0.0 |
Tumor Necrosis Factor-alpha/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
*Ultraviolet Rays | 2 | 0.0 |
Binding Sites | 11 | 0.0 |
Hela Cells | 11 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Myelin Basic Proteins/metabolism | 2 | 3.0 |
Substrate Specificity | 4 | 0.0 |
MAP Kinase Kinase 6 | 4 | 13.0 |
Mitogen-Activated Protein Kinases/antagonists & inhibitors/*metabolism | 2 | 2.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
*DNA-Binding Proteins | 7 | 0.0 |
Genes, Dominant | 2 | 0.0 |
Mitogen-Activated Protein Kinase 11 | 4 | 50.0 |
Mitogen-Activated Protein Kinase 8 | 2 | 2.0 |
Mitogen-Activated Protein Kinase 12 | 2 | 28.0 |
Mitogen-Activated Protein Kinase 9 | 3 | 10.0 |
*Mitogen-Activated Protein Kinases | 9 | 2.0 |
*Trans-Activation (Genetics) | 6 | 0.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*physiology | 2 | 18.0 |
Dactinomycin/pharmacology | 2 | 0.0 |
*Leucine Zippers | 3 | 6.0 |
Transcription Factors/*physiology | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/genetics/*metabolism | 4 | 40.0 |
Dimerization | 4 | 0.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Transcription Factors/genetics/*metabolism | 4 | 0.0 |
Gene Library | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Proto-Oncogene Proteins c-jun/*physiology | 2 | 9.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Consensus Sequence | 4 | 0.0 |
Cytokines/*pharmacology | 2 | 0.0 |
Enzyme Induction | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 2 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Oligodeoxyribonucleotides | 2 | 0.0 |
NIH 3T3 Cells | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Kinetics | 4 | 0.0 |
Protein Kinases/metabolism | 2 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Proto-Oncogene Proteins c-jun/*metabolism | 2 | 2.0 |
Male | 3 | 0.0 |
Dogs | 2 | 0.0 |
Signal Transduction/physiology | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/biosynthesis | 2 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 3 | 1.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Phosphorylation/drug effects | 2 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive | 2 | 8.0 |
Tissue Distribution | 2 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
Apoptosis/*physiology | 2 | 0.0 |
Retinoblastoma Protein/*metabolism | 2 | 1.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Breast Neoplasms | 2 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Plasmids/metabolism | 2 | 0.0 |
RNA, Small Interfering/metabolism | 2 | 1.0 |
Cell Line, Tumor | 3 | 0.0 |
Species Specificity | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
